Golledge, Jonathan, Drovandi, Aaron, Rowbotham, Sophie, Velu, Ramesh, Quigley, Frank, and Jenkins, Jason (2021) Control of modifiable risk factors and major adverse cardiovascular events in people with peripheral artery disease and diabetes. World Journal of Diabetes, 12 (6). pp. 883-892.

Golledge, Jonathan, Yip, Lisan, Fernando, Malindu E., Pinchbeck, Jenna, Rowbotham, Sophie, Jenkins, Jason, and Leicht, Anthony (2021) Relationship between requirement to stop during a six-minute walk test and health-related quality of life, physical activity and physical performance amongst people with intermittent claudication. Annals of Vascular Surgery, 76. pp. 363-369.

Nastasi, Domenico R., Moxon, Joseph V., Norman, Richard, Trollope, Alex F., Rowbotham, Sophie, Quigley, Frank, Jenkins, Jason, and Golledge, Jonathan (2021) The cost-effectiveness of intensive low-density lipoprotein cholesterol lowering in people with peripheral artery disease. Journal of Vascular Surgery, 73 (4). 1396-1403.e3.

Golledge, Jonathan, Rowbotham, Sophie, Velu, Ramesh, Quigley, Frank, Jenkins, Jason, Bourke, Michael, Bourke, Bernie, Thanigaimani, Shiv, Chan, Dick C., and Watts, Gerald F. (2020) Association of serum lipoprotein (a) with the requirement for a peripheral artery operation and the incidence of major adverse cardiovascular events in people with peripheral artery disease. Journal of the American Heart Association, 9 (6). e015355.

Golledge, Jonathan, Pinchbeck, Jenna, Tomee, Stephanie M., Rowbotham, Sophie E., Singh, Tejas P., Moxon, Joseph V., Jenkins, Jason S., Lindeman, Jan H., Dalman, Ronald L., McDonnell, Lori, Fitridge, Robert, Morris, Dylan R., and TEDY Investigators, (2020) Efficacy of Telmisartan to slow growth of small abdominal aortic aneurysms: a randomized clinical trial. Jama Cardiology, 5 (12). pp. 1374-1381.

Golledge, Jonathan, Pinchbeck, Jenna, Rowbotham, Sophie, Yip, Lisan, Jenkins, Jason, Quigley, Frank, and Moxon, Joseph V. (2020) Health-related quality of life amongst people diagnosed with abdominal aortic aneurysm and peripheral artery disease and the effect of fenofibrate. Scientific Reports, 10. 14583.

Golledge, Jonathan, Moxon, Joseph V., Rowbotham, Sophie, Pinchbeck, Jenna, Quigley, Frank, and Jenkins, Jason (2020) High ankle brachial index predicts high risk of cardiovascular events amongst people with peripheral artery disease. PLoS ONE, 15 (11). e0242228.

Golledge, Jonathan, Leicht, Anthony S., Yip, Lisan, Rowbotham, Sophie E., Pinchbeck, Jenna, Jenkins, Jason S., Clapperton, Roslyn, Dally-Watkins, Matthew, Fiatarone Singh, Maria A., Mavros, Yorgi, Noble, Yian, Haghighi, Marjan M., Hollings, Matthew, Parmenter, Belinda J., and Burton, Nicola W. (2020) Relationship between disease specific quality of life measures, physical performance, and activity in people with intermittent claudication caused by peripheral artery disease. European Journal of Vascular and Endovascular Surgery, 59 (6). pp. 957-964.

Moxon, Joseph V., Rowbotham, Sophie E., Pinchbeck, Jenna L., Lazzaroni, Sharon M., Morton, Susan K., Moran, Corey S., Quigley, Frank, Jenkins, Jason S., Reid, Christopher M., Cavaye, Doug, Jaeggi, Rene, and Golledge, Jonathan (2020) A randomised controlled trial assessing the effects of peri-operative fenofibrate administration on abdominal aortic aneurysm pathology: outcomes from the FAME trial. European Journal of Vascular and Endovascular Surgery, 60 (3). pp. 452-460.

Thomas Manapurathe, Diana, Moxon, Joseph Vaughan, Krishna, Smriti Murali, Rowbotham, Sophie, Quigley, Frank, Jenkins, Jason, Bourke, Michael, Bourke, Bernard, Jones, Rhondda E., and Golledge, Jonathan (2019) Cohort study examining the association between blood pressure and cardiovascular events in patients with peripheral artery disease. Journal of the American Heart Association, 8. e010748.

Golledge, Jonathan, Morris, Dylan R., Pinchbeck, Jenna, Rowbotham, Sophie, Jenkins, Jason, Bourke, Michael, Bourke, Bernard, Norman, Paul E., Jones, Rhonda, and Moxon, Joseph V. (2019) Metformin prescription is associated with reduced risk of surgical repair and rupture-related mortality in patients with abdominal aortic aneurysm. European Journal of Vascular and Endovascular Surgery, 57 (1). pp. 94-101.

Golledge, J., Moxon, J.V., Rowbotham, S., Pinchbeck, J., Yip, L., Velu, R., Quigley, F., Jenkins, J., and Morris, D. (2018) Risk of major amputation in patients with intermittent claudication undergoing early revascularization. British Journal of Surgery, 105 (6). pp. 699-708.

Pinchbeck, Jenna L., Moxon, Joseph V., Rowbotham, Sophie E., Bourke, Michael, Lazzaroni, Sharon, Morton, Susan K., Matthews, Evan O., Hendy, Kerolos, Jones, Rhondda E., Bourke, Bernie, Jaeggi, Rene, Favot, Danella, Quigley, Frank, Jenkins, Jason S., Reid, Christopher M., Velu, Ramesh, and Golledge, Jonathan (2018) A randomized placebo-controlled trial assessing the effect of 24 weeks fenofibrate therapy on circulating markers of abdominal aortic aneurysm: outcomes from the FAME-2 trial. Journal of the American Heart Association, 7 (19). e009866.

Rowbotham, Sophie E., Bourke, Bernie, Bourke, Michael, Jaeggi, Rene, Jenkins, Jason S., Moxon, Joseph V., Pinchbeck, Jenna L., Reid, Christopher M., Velu, Ramesh, and Golledge, Jonathan (2016) Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME)-2: the study protocol for a multi-centre, randomised, placebo-controlled trial. International Journal of Clinical Trials, 3 (4). pp. 217-224.